Condition: Urinary Bladder Neoplasms · Sponsor: First Affiliated Hospital of Fujian Medical University
The aim of this trial is to investigate the value of FAPI PET/MRI, FDG PET/MRI and MRI in diagnosing MIBC and predicting the efficacy of neoadjuvant therapy for MIBC patients, so as to guide the clinic to adjust the treatment plan in time and benefit MIBC patients.
This description comes directly from the study's public registry record.
Ning Xu, Doctor · 13235907575 · drxun@fjmu.edu.cn
Xiao-Dong Li, Master · 15980273075 · lixiaodong@fjmu.edu.cn
Always discuss trial participation with your own doctor first.
| first hospital affiliated of Fujian medical university | Fuzhou, Fujian, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06421142